drugset / Trial / NCT03611348

Microneedling and Latanoprost in Acrofacial Vitiligo

NCT03611348

Phase 2/3 Unknown 70 enrolled Sohag University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To compare efficacy of topical latanoprost preceded by microneedling versus topical latanoprost alone in treatment of acrofacial vitiligo.

Timeline

Start
2018-09-01
Primary completion
2019-09-01
Completion
2019-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule 0.005 % Topical

Indications